{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:46:38Z","timestamp":1792003598181,"version":"4.4.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","aaojournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.ophtha.2016.02.044","type":"journal-article","created":{"date-parts":[[2016,4,13]],"date-time":"2016-04-13T20:21:50Z","timestamp":1460578910000},"page":"1449-1457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["A Clinical Trial Comparing the Safety and Efficacy of Topical Tacrolimus versus Methylprednisolone in Ocular Graft-versus-Host Disease"],"prefix":"10.1016","volume":"123","clinical-trial-number":[{"clinical-trial-number":"nct01977781","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Tulio B.","family":"Abud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Amparo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ujwala S.","family":"Saboo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Di Zazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas H.","family":"Dohlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph B.","family":"Ciolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9313-2939","authenticated-orcid":false,"given":"Pedram","family":"Hamrah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Dana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2016.02.044_bib1","doi-asserted-by":"crossref","unstructured":"Shikari H, Antin JH, Dana R. Ocular graft-versus-host disease: a review. Surv Ophthalmol 58:233\u2013251.","DOI":"10.1016\/j.survophthal.2012.08.004"},{"key":"10.1016\/j.ophtha.2016.02.044_bib2","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/ACI.0b013e328357b4b9","article-title":"Ocular graft-versus-host disease","volume":"12","author":"Hessen","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.ophtha.2016.02.044_bib3","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1177\/096368970901805-620","article-title":"Comparative study of the cellular pharmacodynamics of calcineurin inhibitors between patients with chronic renal failure awaiting renal transplantation and cirrhosis patients awaiting liver transplantation","volume":"18","author":"Kihara","year":"2009","journal-title":"Cell Transplant"},{"key":"10.1016\/j.ophtha.2016.02.044_bib4","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3899\/jrheum.090048","article-title":"Tacrolimus, a calcineurin inhibitor, overcomes treatment unresponsiveness mediated by P-glycoprotein on lymphocytes in refractory rheumatoid arthritis","volume":"37","author":"Suzuki","year":"2010","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.ophtha.2016.02.044_bib5","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1345\/aph.18417","article-title":"Tacrolimus: an alternative for graft-versus-host disease prevention","volume":"34","author":"Lee","year":"2000","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ophtha.2016.02.044_bib6","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/ICO.0b013e31823f8c9b","article-title":"Clinical treatment of dry eye using 0.03% tacrolimus eye drops","volume":"31","author":"Moscovici","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2016.02.044_bib7","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.clae.2015.04.004","article-title":"Treatment of Sj\u00f6gren\u2019s syndrome dry eye using 0.03% tacrolimus eye drop: prospective double-blind randomized study","volume":"38","author":"Moscovici","year":"2015","journal-title":"Cont Lens Anterior Eye"},{"key":"10.1016\/j.ophtha.2016.02.044_bib8","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/eye.2011.75","article-title":"Topical 0.005% tacrolimus eye drop for refractory vernal keratoconjunctivitis","volume":"25","author":"Kheirkhah","year":"2011","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ophtha.2016.02.044_bib9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1089\/jop.2009.0087","article-title":"A\u00a0randomized, placebo-controlled clinical trial of tacrolimus ophthalmic suspension 0.1% in severe allergic conjunctivitis","volume":"26","author":"Ohashi","year":"2010","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.ophtha.2016.02.044_bib10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2332\/allergolint.11-OA-0349","article-title":"Blood level of tacrolimus in patients with severe allergic conjunctivitis treated by 0.1 % tacrolimus ophthalmic suspension","volume":"61","author":"Ebihara","year":"2012","journal-title":"Allergol Int"},{"key":"10.1016\/j.ophtha.2016.02.044_bib11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1432-2277.2004.00006.x","article-title":"Topical FK506 as immunoprophylaxis after allogeneic penetrating normal-risk keratoplasty: a randomized clinical pilot study","volume":"18","author":"Reinhard","year":"2005","journal-title":"Transpl Int"},{"key":"10.1016\/j.ophtha.2016.02.044_bib12","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0161-6420(00)00347-X","article-title":"Flow cytometric analysis of conjunctival epithelium in ocular rosacea and keratoconjunctivitis sicca","volume":"107","author":"Pisella","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2016.02.044_bib13","first-page":"1492","article-title":"Conjunctival HLA-DR and CD8 expression detected by impression cytology in ocular graft versus host disease","volume":"19","author":"Eberwein","year":"2013","journal-title":"Mol Vis"},{"key":"10.1016\/j.ophtha.2016.02.044_bib14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.exer.2013.03.018","article-title":"HLA-DR expression as a biomarker of inflammation for multicenter clinical trials of ocular surface disease","volume":"111","author":"Epstein","year":"2013","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ophtha.2016.02.044_bib15","first-page":"90","article-title":"Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A","volume":"42","author":"Brignole","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2016.02.044_bib16","doi-asserted-by":"crossref","first-page":"e591","DOI":"10.1111\/j.1755-3768.2011.02196.x","article-title":"A\u00a0multicentre, double-masked, randomized, controlled trial assessing the effect of oral supplementation of omega-3 and omega-6 fatty acids on a conjunctival inflammatory marker in dry eye patients","volume":"89","author":"Brignole-Baudouin","year":"2011","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.02.044_bib17","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/978-1-4615-0717-8_5","article-title":"Flow cytometric analysis of the inflammatory marker HLA DR in dry eye syndrome: results from 12 months of randomized treatment with topical cyclosporin A","volume":"506","author":"Baudouin","year":"2002","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.ophtha.2016.02.044_bib18","first-page":"337","article-title":"Flow cytometry in impression cytology during keratoconjunctivitis sicca: effects of topical cyclosporin A on HLA DR expression","volume":"26","author":"Galatoire","year":"2003","journal-title":"J\u00a0Fr Ophtalmol"},{"key":"10.1016\/j.ophtha.2016.02.044_bib19","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0161-6420(99)90171-9","article-title":"Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sj\u00f6gren syndrome","volume":"106","author":"Marsh","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2016.02.044_bib20","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1089\/jop.2006.0091","article-title":"Recurrence after topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sj\u00f6gren\u2019s syndrome","volume":"23","author":"Hong","year":"2007","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.ophtha.2016.02.044_bib21","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ajo.2014.11.035","article-title":"Long-term result of maintenance treatment with tacrolimus ointment in chronic ocular graft-versus-host disease","volume":"159","author":"Jung","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.02.044_bib22","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1089\/jop.2012.0265","article-title":"Treatment of refractory dry eye associated with graft versus host disease with 0.03% tacrolimus eyedrops","volume":"29","author":"Sanz-Marco","year":"2013","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.ophtha.2016.02.044_bib23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3341\/kjo.2012.26.4.241","article-title":"Therapeutic effect of 0.03 % tacrolimus ointment for ocular graft versus host disease and vernal keratoconjunctivitis","volume":"26","author":"Ryu","year":"2012","journal-title":"Korean J Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.02.044_bib24","first-page":"221","article-title":"Report of the National Eye Institute\/Industry workshop on Clinical Trials in Dry Eyes","volume":"21","author":"Lemp","year":"1995","journal-title":"CLAO J"},{"key":"10.1016\/j.ophtha.2016.02.044_bib25","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.118.5.615","article-title":"Reliability and validity of the Ocular Surface Disease Index","volume":"118","author":"Schiffman","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.02.044_bib26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/jop.2011.0108","article-title":"Ocular safety and pharmacokinetics study of FK506 suspension eye drops after corneal transplantation","volume":"28","author":"Yuan","year":"2012","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.ophtha.2016.02.044_bib27","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/ICO.0b013e3181a16472","article-title":"High-frequency topical cyclosporine 0.05% in the treatment of severe dry eye refractory to twice-daily regimen","volume":"28","author":"Dastjerdi","year":"2009","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2016.02.044_bib28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4137\/OED.S16067","article-title":"Safety and efficacy of cyclosporine in the treatment of chronic dry eye","volume":"6","author":"Schultz","year":"2014","journal-title":"Ophthalmol Eye Dis"},{"key":"10.1016\/j.ophtha.2016.02.044_bib29","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1742-481X.2012.00950.x","article-title":"Effects of immunosuppressive therapy on wound healing","volume":"10","author":"Bootun","year":"2013","journal-title":"Int Wound J"},{"key":"10.1016\/j.ophtha.2016.02.044_bib30","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1016\/j.crohns.2013.04.018","article-title":"Mucosal healing with oral tacrolimus is associated with favorable medium- and long-term prognosis in steroid-refractory\/dependent ulcerative colitis patients","volume":"7","author":"Miyoshi","year":"2013","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.ophtha.2016.02.044_bib31","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/exd.12131","article-title":"Topical tacrolimus does not negatively impact acute skin wound healing","volume":"22","author":"Namkoong","year":"2013","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.ophtha.2016.02.044_bib32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10059-009-0114-z","article-title":"Tacrolimus differentially regulates the proliferation of conventional and regulatory CD4(+) T cells","volume":"28","author":"Kogina","year":"2009","journal-title":"Mol Cells"},{"key":"10.1016\/j.ophtha.2016.02.044_bib33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/sj.bmt.1705900","article-title":"Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease","volume":"41","author":"Wang","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ophtha.2016.02.044_bib34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ajo.2011.01.019","article-title":"Prospective, randomized study of the efficacy of systemic cyclosporine in high-risk corneal transplantation","volume":"152","author":"Shimazaki","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.02.044_bib35","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/01.ico.0000208818.47861.1d","article-title":"Ophthalmic cyclosporine use in ocular GVHD","volume":"25","author":"Lelli","year":"2006","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2016.02.044_bib36","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/ICO.0000000000000123","article-title":"Topical cyclosporine A in the treatment of dry eye: a systematic review and meta-analysis","volume":"33","author":"Zhou","year":"2014","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2016.02.044_bib37","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0161-6420(99)00176-1","article-title":"Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group","volume":"107","author":"Sall","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2016.02.044_bib38","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1001\/archophthalmol.2009.356","article-title":"Minimal clinically important difference for the ocular surface disease index","volume":"128","author":"Miller","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.02.044_bib39","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1136\/bjophthalmol-2013-304072","article-title":"Systematic review of randomised clinical trials on topical ciclosporin A for the treatment of dry eye disease","volume":"98","author":"Sacchetti","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.02.044_bib40","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/01.ico.0000208813.17367.0c","article-title":"Efficacy of topical cyclosporine 0.05% in the treatment of dry eye associated with graft versus host disease","volume":"25","author":"Rao","year":"2006","journal-title":"Cornea"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642016003316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642016003316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T11:50:46Z","timestamp":1567770646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642016003316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0161642016003316"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2016.02.044","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Clinical Trial Comparing the Safety and Efficacy of Topical Tacrolimus versus Methylprednisolone in Ocular Graft-versus-Host Disease","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2016.02.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}